ArticleFrontiers in immunology2022

Efficacy of Immune Checkpoint Inhibitors in Patients With EGFR Mutated NSCLC and Potential Risk Factors Associated With Prognosis: A Single Institution Experience.

Menglin Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.